✦ LIBER ✦

515 Everolimus for Calcineurin Inhibitor Minimization in Lung Transplant Recipients with Chronic Renal Insufficiency

✍ Scribed by K. Schoeppler; D. Lyu; I. Kim; T. Grazia; J. Crossno; U. Christians; M.R. Zamora

Book ID: 116524168
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 203 KB
Volume: 31
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2012.01.527

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

45: Combination of Everolimus with Low-D

45: Combination of Everolimus with Low-Dose Calcineurin-Inhibitors in Lung Transplant Recipients with Chronic Renal Insufficiency

✍ M.A.R. Hoda; P. Jaksch; B. Zweytick; S. Taghavi; G. Lang; C. Aigner; M. Gaugg; M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Sirolimus therapy in orthotopic liver tr

Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency

✍ G.W Neff; M Montalbano; G Slapak-Green; D Meyer; T Berney; K Safdar; E.R Schiff; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Use of mTOR inhibitors in chronic heart

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

✍ Gonzalez-Vilchez, F.; Vazquez de Prada, J.A.; Paniagua, M.J.; Gomez-Bueno, M.; A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 505 KB

53 Everolimus Introduction and Calcineur

53 Everolimus Introduction and Calcineurin Reduction in Thoracic Transplant Recipients with Advanced Chronic Renal Failure

✍ S. Arora; B. Rundqvist; S.-A. Mortensen; H. Eiskjær; G. Riise; L. Mared; O. Bjør 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

Rapamycin for treatment of renal insuffi

Rapamycin for treatment of renal insufficiency related to calcineurin inhibitors in liver transplant recipients

✍ Adil Habib; Bruce R. Bacon; Alex S. Befeler; Sunil Ramrakhiani; Sanjay Ramrakhia 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB